Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events

Medicilon Events

Hot information:
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon FTE services & FFS services - flexible and efficient cooperation model| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon
Feb 03,2016
The special report written by Medicilon CEO, Dr. Chunlin Chen, was posted on Pharmaceutical Forum
The special report written by Medicilon CEO, Dr. Chunlin Chen, was posted on Pharmaceutical Forum of Zhejiang Pharmaceutical Association Dr. Chunlin Chen, CEO of Medicilon,
More
The special report written by Medicilon CEO, Dr. Chunlin Chen, was posted on Pharmaceutical Forum
Feb 03,2016
Medicilon is featured in Chemical & Engineering News (C&EN): "How The Internet Changed Chemistry”
The Chemical & Engineering News (C&EN) recently published a special issue "How The Internet Changed Chemistry”, which presented a very important point saying that "Internet
More
Medicilon is featured in Chemical & Engineering News (C&EN): "How The Internet Changed Chemistry”
Jan 20,2016
IVIS Lumina Series III Pre-clinical In Vivo Imaging Systems
01/20/2016 Medicilon Instruments' family has a new member: IVIS Lumina lt Series III Pre-clinical In Vivo Imaging Systems Medicilon new instrument, IVIS Lumina Series Pre-clinical
More
IVIS Lumina Series III Pre-clinical In Vivo Imaging Systems
Jan 07,2016
Medicilon installed Triple Quad 6500 system and in operation now
01/08/2016, Medicilon recently purchased Triple Quad 6500+ made by SCIEX for Biological Services.  This new purchase will enable Medicilon to expand and strength the Biological
More
Medicilon installed Triple Quad 6500  system and in operation now
Dec 25,2015
Christmas Greeting From MEDICILON!
Dear Colleagues and Friends,       Warmest Holiday Greetings to you and your families fromMEDICILON !       As the end of year is
More
Christmas Greeting From MEDICILON!
Nov 20,2015
Medicilon Biological Drugs Antibodies Laboratory Will Be Operated Soon
Medicilon's Biological Drugs (Antibodies) Laboratory will be operated soon.  Medicilon could provide more biology services to our clients combined with our usual biology services.  The
More
Medicilon Biological Drugs Antibodies Laboratory Will Be Operated Soon
Nov 12,2015
Biopharmaceutical Stability Research Test
The newly built vivarium by Medicilon has passed the audition of Shanghai Animal Committee.  Combined with the original vivarium, the vivarium capacity of Medicilon is
More
Biopharmaceutical Stability Research Test
Sep 17,2015
Dr. Chunlin Chen will participate the Zhejiang Overseas Senior-Level Biomedical Annual Meeting
The Zhejiang Overseas Senior-Level Organization was founded in Feb 2011 by entrepreneur and the scientists.  The organization currently has about 1,000 members from "Thousand People
More
Dr. Chunlin Chen will participate the Zhejiang Overseas Senior-Level Biomedical Annual Meeting
Jul 30,2015
Preclinical CRO - Medicilon
Medicilon (stock code: 688202. SH) is a drug research and development outsourcing service company (CRO). Pharmacology, pharmacokinetics, and toxicology evaluation are comprehensive technical service platforms that meet international standards.
More
Preclinical CRO - Medicilon
Jun 11,2015
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Suzhou NeuPharma Co., Ltd announced that it has initiated the first-in-human Phase I clinical trial of RX108 in Australia.  RX108 is a novel small-molecule inhibitor
More
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Jun 09,2015
Medicilon successfully held a seminar in Tokyo and Osaka, Japan from June 3-4
Dr. Chunlin Chen, Medicilon's CEO, was the host of the seminar in Tokyo and Osaka and gave a wonderful speech with the topic "Current Pharmaceutical
More
Medicilon successfully held a seminar in Tokyo and Osaka, Japan from June 3-4
Mar 31,2015
Medicilon Successfully Hosted a CFDA IND Seminar in Seoul, South Korea
On March 18, Medicilon hosted a CFDA IND seminar with Korea Pharmaceutical Manufacturers Association (KPMA) in Seoul, South Korea.  The seminar's topic was "Experience Sharing
More
Medicilon Successfully Hosted a CFDA IND Seminar in Seoul, South Korea